Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Grant Lofness Steele, M.D.

Concepts (39)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Grant Steele's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Grant Steele has written about over time.
Analgesics, Opioid, 3 publications between 2017 and 2020, average publication date August 2018. Neoplasm Staging, 2 publications between 2018 and 2020, average publication date May 2019. Adenocarcinoma, 1 publications between 2020 and 2020, average publication date July 2020. Pancreatic Neoplasms, 1 publications between 2020 and 2020, average publication date July 2020. Receptors, Opioid, mu, 1 publications between 2020 and 2020, average publication date July 2020. Survival Rate, 1 publications between 2020 and 2020, average publication date July 2020. Staphylococcus epidermidis, 1 publications between 2023 and 2023, average publication date February 2023. Urinalysis, 1 publications between 2023 and 2023, average publication date February 2023. Urinary Tract Infections, 1 publications between 2023 and 2023, average publication date February 2023. Prostatic Neoplasms, 3 publications between 2023 and 2024, average publication date September 2023. Health Services Accessibility, 1 publications between 2024 and 2024, average publication date June 2024. Healthcare Disparities, 1 publications between 2024 and 2024, average publication date June 2024.

To see the data from this visualization as text, click here.
Steele's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (39)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.